Shrinking lung syndrome with favourable response to belimumab and corticosteroids alone
European Journal of Case Reports in Internal Medicine · 16.10.2026 · 13 (11)
DOI: 10.12890/2026_007315 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Case Reports in Internal Medicine, online erschienen am 16.10.2026. Verfasst von Rémy Père und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pneumology, Centre Hospitalier de Luxembourg, Luxembourg, Luxembourg. Die Arbeit nennt 12 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Introduction
Shrinking lung syndrome (SLS) is a rare complication of systemic lupus erythematosus. It is characterized by dyspnoea and a restrictive ventilatory defect, often associated with pleuritic chest pain. Given its rarity, there is no standardized treatment. Most published case reports describe a favourable outcome with corticosteroids alone or in combination with other immunosuppressive agents, such as cyclophosphamide or rituximab. Only a few cases treated with belimumab have been reported. Case description: We present the case of a 16-year-old female presenting with pleuritic chest pain, orthopnoea, and a restrictive ventilatory defect. Further investigations revealed positive antinuclear antibodies, a small left pleural effusion, and mild elevation of the left hemidiaphragm, findings consistent with SLS. Treatment with corticosteroids and belimumab was initiated, leading to significant clinical and biological improvement.
Conclusion
This case highlights the potential role of belimumab as a first-line treatment for SLS in combination with corticosteroids alone.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pneumology, Centre Hospitalier de Luxembourg, Luxembourg, Luxembourg.
- Department of Immuno-Allergology, Centre Hospitalier de Luxembourg, Luxembourg, Luxembourg.
Zitieren
APA
Père, R., Le Goueff, A., & Nguenang, M. (2026). Shrinking lung syndrome with favourable response to belimumab and corticosteroids alone. European Journal of Case Reports in Internal Medicine, 13(11). https://doi.org/10.12890/2026_007315
Vancouver
Père R, Le Goueff A, Nguenang M. Shrinking lung syndrome with favourable response to belimumab and corticosteroids alone. European Journal of Case Reports in Internal Medicine. 2026;13(11). doi:10.12890/2026_007315
BibTeX
@article{Pre2026,
author = {Père, Rémy and Le Goueff, Anouk and Nguenang, Marina},
title = {Shrinking lung syndrome with favourable response to belimumab and corticosteroids alone},
journal = {European Journal of Case Reports in Internal Medicine},
year = {2026},
volume = {13},
number = {11},
doi = {10.12890/2026_007315}
}
EUVIMED